StockNews.AI
LFMD
StockNews.AI
113 days

LifeMD Acquires Women's Health Provider Optimal Human Health MD to Accelerate Entry into the Women's Health Market

1. LifeMD acquires Optimal, entering the women's health market. 2. New services will address hormone health and wellness, launching summer 2025. 3. Women's health market poised for $60–70 billion growth by 2030. 4. Optimal’s founder joins LifeMD to shape women's health strategy. 5. LifeMD leverages existing infrastructure for comprehensive virtual care delivery.

M&A
+38.01%Current Return
VS
+0.81%S&P 500
$6.0904/28 08:04 AM EDTEvent Start
$8.40504/29 02:37 PM EDTLatest Updated
10m saved
Insight
Article

FAQ

Why Bullish?

The acquisition enhances LifeMD's value proposition and market reach, similar to past successful expansions like Rex MD.

How important is it?

The acquisition significantly enhances LifeMD's service offerings in a growing market, indicating solid growth potential.

Why Long Term?

The women's health services could establish a sustainable revenue stream, benefiting the company's long-term growth.

Related Companies

RMDCVACMDGL
Acquisition Establishes Clinical and Operational Foundation for LifeMD’s Comprehensive Women’s Health Offering, Launching Summer 2025 April 28, 2025 08:00 ET  | Source: LifeMD, Inc. NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced the acquisition of key assets from Optimal Human Health MD (“Optimal”), a nationwide women’s health virtual care provider. This strategic acquisition marks LifeMD’s official entry into the women’s health market and establishes a scalable clinical foundation for a comprehensive virtual health program under the LifeMD brand, focused on hormone health, bone density, metabolism, and long-term wellness. With women’s health historically underserved—particularly in areas such as perimenopause, menopause, and hormonal balance—LifeMD’s expansion addresses a significant unmet need for accessible, personalized, and high-quality care. The new women’s health offering is expected to launch this summer and will provide services through LifeMD’s vertically integrated platform. “Expanding LifeMD’s virtual care, prescription, and wellness portfolio into adjacent markets where traditional U.S. healthcare has consistently failed to meet the needs of patients—particularly women—is central to our growth strategy,” said Jessica Friedeman, Chief Marketing Officer and Head of Women’s Health at LifeMD. “Our upcoming women’s health programs are particularly compelling because they allow us to fully leverage our national provider network, partnerships with Quest and Labcorp, in-house mail-order pharmacy, behavioral health services, and nutrition and wellness capabilities. Together, these assets position us to build what we believe will be the most comprehensive virtual-first women’s health offering in the country. Just as importantly, many of these services will be accessible through private and government insurance, further increasing affordability and reach for our patients.” Despite increasing awareness, women’s health remains one of the most underserved areas in medicine—extending far beyond maternity and reproductive care. Natural transitions like menopause—and conditions like osteoporosis—are chronically underdiagnosed and/or undertreated: only one in four women seeks treatment for menopause-related symptoms, and while women represent 80% of osteoporosis cases, over two-thirds remain undiagnosed. According to BCG, these two areas alone represent a projected market opportunity of $60–70 billion by 2030—over six times larger than today—highlighting the scale and urgency of building solutions that meet the unique health needs of women at every stage of life. The transaction brings on board Optimal’s highly trained team—including nurse practitioners, registered dietitians, and patient care staff—as well as Dr. Doug Lucas, Optimal’s founder and a widely respected leader in osteoporosis reversal and hormone optimization. Dr. Lucas is the author of two best-selling books, The Osteoporosis Breakthrough and Top 10 Reasons Why Your Hormones Are Failing You, and hosts the popular YouTube channel “The Dr. Doug Show: Bones, Hormones, and HealthSpan.” He brings decades of clinical experience and thought leadership to LifeMD, where he will play a central role in shaping the company’s women’s health strategy. “LifeMD’s platform provides the reach and operational sophistication to bring world-class women’s health care to a broader population,” said Dr. Lucas. “With increased awareness around menopause-related symptoms as well as conditions like osteoporosis—along with rising demand for personalized wellness solutions—I'm excited to expand the work we started at Optimal and deliver next-generation care through LifeMD.” The acquisition is aligned with LifeMD’s broader strategy of scaling high-demand specialty care verticals through proven clinical models and platform integration, following the success of Rex MD in men’s health. LifeMD is uniquely equipped to deliver differentiated care at scale, supported by its 50-state affiliated medical group, national lab and pharmacy infrastructure, and an expanding patient base across both cash-pay and insurance-covered models. Interested patients can join the waitlist at https://lifemd.com/womens-health/. About LifeMD, Inc. LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s and women’s health, weight management, and hormone therapy. The Company leverages a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a 22,500-square-foot affiliated pharmacy, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit LifeMD.com. Cautionary Note Regarding Forward Looking Statements This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended; Section 21E of the Securities Exchange Act of 1934, as amended; and the safe harbor provision of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this news release may be identified by the use of words such as: “believe,” “expect,” “anticipate,” “project,” “should,” “plan,” “will,” “may,” “intend,” “estimate,” “predict,” “continue,” and “potential,” or, in each case, their negative or other variations or comparable terminology referencing future periods. Examples of forward-looking statements include, but are not limited to, statements regarding our financial outlook and guidance, short and long-term business performance and operations, future revenues and earnings, regulatory developments, legal events or outcomes, ability to comply with complex and evolving regulations, market conditions and trends, new or expanded products and offerings, growth strategies, underlying assumptions, and the effects of any of the foregoing on our future results of operations or financial condition. Forward-looking statements are not historical facts and are not assurances of future performance. Rather, these statements are based on our current expectations, beliefs, and assumptions regarding future plans and strategies, projections, anticipated and unanticipated events and trends, the economy, and other future conditions, including the impact of any of the aforementioned on our future business. As forward-looking statements relate to the future, they are subject to inherent risk, uncertainties, and changes in circumstances and assumptions that are difficult to predict, including some of which are out of our control. Consequently, our actual results, performance, and financial condition may differ materially from those indicated in the forward-looking statements. These risks and uncertainties include, but are not limited to, “Risk Factors” identified in our filings with the Securities and Exchange Commission, including, but not limited to, our most recently filed Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and any amendments thereto. Even if our actual results, performance, or financial condition are consistent with forward-looking statements contained in such filings, they may not be indicative of our actual results, performance, or financial condition in subsequent periods. Any forward-looking statement made in the news release is based on information currently available to us as of the date on which this release is made. We undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as may be required under applicable law or regulation. Investor ContactMarc Benathen, Chief Financial Officermarc@lifemd.com Media Contact Jessica Friedeman, Chief Marketing Officerpress@lifemd.com

Related News